Efficacy and Safety of Cefepime/Nacubactam or Aztreonam/Nacubactam Compared to Imipenem/Cilastatin in Subjects With Complicated Urinary Tract Infections or Acute Uncomplicated Pyelonephritis

NCT05887908 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

614

Enrollment

INDUSTRY

Sponsor class

Conditions

Complicated Urinary Tract Infection
Acute Pyelonephritis
cUTI
AP

Interventions

DRUG: co-administration of cefepime and nacubactam
DRUG: co-administration of aztreonam and nacubactam
DRUG: imipenem/cilastatin

Sponsor

Meiji Seika Pharma Co., Ltd.